| RS1805578327 |
CYP7B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 5A, Hereditary spastic paraplegia 5A |
| RS1805601610 |
MNX1
|
Health Risk |
Likely pathogenic |
— |
| RS1805613575 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805615555 |
SYNCRIP
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1805694320 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805723571 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805724910 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805733963 |
CHD7
|
Health Risk |
Likely pathogenic |
— |
| RS1805737676 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1805742175 |
TTPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS1805742556 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS1805743392 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805745954 |
TTPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS1805748326 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS1805748956 |
TTPA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1805754682 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1805777437 |
FOXP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1805809633 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS1805830692 |
ARFGEF1
|
Health Risk |
Pathogenic |
Delayed speech and language development, Atypical behavior |
| RS1805853366 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1805854701 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1805854944 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1805856024 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1805857731 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1805867082 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1805879513 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive retinitis pigmentosa, Retinitis pigmentosa 1 |
| RS1805889752 |
BPNT2
|
Health Risk |
Likely pathogenic |
Chondrodysplasia with joint dislocations, gPAPP type |
| RS1805900125 |
RP1
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS1805920281 |
ZP3
|
Health Risk |
Pathogenic |
— |
| RS1805943625 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1805946988 |
CHD7
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1805949598 |
CHD7
|
Health Risk |
Likely pathogenic |
— |
| RS1805978316 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1805984836 |
RP1
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Retinitis pigmentosa 1 |
| RS1805986090 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1806006713 |
ATP6V0A4
|
Health Risk |
Pathogenic |
Distal renal tubular acidosis, Distal renal tubular acidosis |
| RS1806015333 |
ATP6V0A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular acidosis, distal |
| RS1806016526 |
ATP6V0A4
|
Health Risk |
Likely pathogenic |
— |
| RS1806020324 |
RP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1806028872 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806031833 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806032708 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806033441 |
RP1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1806033536 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 1, Retinitis pigmentosa |
| RS1806033714 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806033844 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1806036718 |
RP1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1806037949 |
RP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal disorder |
| RS1806040543 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806041389 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1806042579 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806043158 |
RP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1806048148 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1806054045 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1806057300 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1806057524 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806061474 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806069993 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806079109 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806079331 |
RP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 1 |
| RS1806088386 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806088809 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive retinitis pigmentosa, Retinitis pigmentosa 1 |
| RS1806096563 |
RP1
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS1806099964 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806103875 |
RP1
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS1806120012 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806124182 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1806128079 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806128576 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1806144355 |
RP1
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS1806147660 |
RP1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 1, Retinitis pigmentosa 1 |
| RS1806153102 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806160527 |
RP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1806171937 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806173195 |
CHD7
|
Health Risk |
Pathogenic/Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1806173661 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1806177003 |
RP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1806185357 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1806199541 |
RP1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 1, Retinitis pigmentosa 1 |
| RS1806205612 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806207146 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1806539260 |
SYNCRIP
|
Health Risk |
Likely pathogenic |
— |
| RS1806573538 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1806590811 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1806601043 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1806602099 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS180670511 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS180671269 |
DUOX2
|
Health Risk |
Pathogenic |
Thyroid dyshormonogenesis 6, DUOX2-related disorder |
| RS1806730582 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS180673806 |
FCSK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS180675584 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1806756940 |
FOXP2
|
Health Risk |
Pathogenic |
— |
| RS180678267 |
KNL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 4, primary |
| RS180680111 |
THPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombocythemia 1, Thrombocythemia 1 |
| RS180683888 |
POR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS1806900857 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS1806901488 |
PEX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5B |
| RS180691490 |
DOCK10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1806926984 |
PEX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS1806929934 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |